TozziniFreire Advogados

Follow

Brazilian legal system: civil law sprinkled with common law elements

July 17 2018 Even though Brazil is a civil law country, the New Civil Procedure Code of 2015 has brought elements of common law jurisdictions to the Brazilian…

Governo Anuncia 34 Projetos para o PPI

September 19 2016 O Governo Federal anunciou, na ltima terafeira (13), aps a primeira reunio do Conselho do Programa de Parceria de Investimentos (PPI), o Projeto…

Resoluções CNSP nºs 294, 295, 296, 297, 300, 301 e 302 e Circular SUSEP Nº 480

January 16 2014 Entre setembro e dezembro de 2013, foram publicadas diversas novas normas aplicáveis ao mercado segurador. As normas trazem inovacoes…

Brazilian arbitration: the booming years

June 17 2014 Not so long ago, the general perception within the Brazilian legal community was that the number of seminars, symposia and congress about arbitration…

In review: digital markets, funding and payment services in Brazil

April 22 2022 An overview of key issues surrounding digital markets, payment services and funding for fintech businesses operating in Brazil, with particular regard to recent developments.

An interview with TozziniFreire Advogados discussing Project Finance in Brazil

March 23 2023 Important projects have been developed in Brazil over the past year, as part of a push by the federal and state governments for their concession and…

Project Finance: Introduction

March 23 2023 <p>"With the more severe restrictions of the pandemic finally behind us, the pace of infrastructure projects in the world has..."</p>

An Interview with TozziniFreire Advogados Introduction to global project finance trends

March 22 2023 "With the more severe restrictions of the pandemic finally behind us, the pace of infrastructure projects in the world has..."

Project Finance: Brazil

March 22 2023 <p>"Important projects have been developed in Brazil over the past year, as part of a push by the federal and state..."</p>

In review: the life sciences regulatory regime in Brazil

March 2 2023 This article reviews the essential regulatory considerations surrounding medicines and medical devices in Brazil, including clinical trials and marketing authorisations.